Skip to main content

Headlines

Takeda's Zasocitinib Shows Superior Skin Clearance In Phase 3 Psoriasis Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Galderma's Nemluvio Shows Sustained Three-Year Benefits In Atopic Dermatitis
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Immix Biopharma's NXC-201 Shows 89% Complete Response Rate In AL Amyloidosis
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
UniQure's AMT-130 Shows Continued Slowing Of Huntington's Disease Progression
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
J&J's IMAAVY Shows Sustained Disease Control In New GMG Data
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Cartesian's Descartes-08 Shows Durable Responses In Myasthenia Gravis
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Cellectar's Iopofosine I 131 Shows Positive Data In Waldenström Macroglobulinemia
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Lilly's Zepbound Shows Greater Weight Loss Than Wegovy HD In New Analysis
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Gilead's Seladelpar Shows Major Liver Disease Progression Improvement, Itch Reduction In PBC Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
This 1 Chart Shows How Nvidia Became the Most Explosive "Magnificent Seven" Stock
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
ARS Pharma's Neffy Shows Rapid Symptom Control In Phase 2 Urticaria Clinical Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Social Security: Research Shows This Age Is the Best to Take Benefits -- but There's a Big Caveat
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
ViiV Healthcare's Cabenuva Shows Superiority In HIV Viral Load Suppression : Interim Trial Analysis
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets